Researchers in the UK will soon start trialling blood tests that promise to diagnose dementia at clinics across the country in the hope of having them in rout
A new centre is to be set up in the UK to provide virtual reality-assisted training in medicines manufacturing, providing students with ‘near to real life’ experiences of
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh